Knowledge Center

Patent / Jan 01, 2013

Application of high dose compounds via inhalation for treatment of pulmonary diseases

Authors:
  • Pedro Mendes
  • Isabel Lopes
  • Jason Suggett
  • Phillip Nelson
Source:
WO 2013104892

The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.

Also in the Knowledge Center

Related Content

Potent compounds

Safety first

Page
Read more

The ËÄÉ«AV Experience - Lisbon

Welcome to Lisbon! Part of The ËÄÉ«AV Experience is ensuring your trip is unforgettable. Explore our suggestions for iconic attractions, exquisite cuisine, and get ready to feel the magic of this vibrant city.

Page
Read more

Jet milling

Jet milling is widely used in the pharmaceutical industry and remains the leading technology for particle size reduction and is most commonly used for having consistent and uniform particles during formulation.

Page
Read more